A powerful lobby of over 8.5 lakh chemist outlets across India, called the All India Organisation of Chemists and Druggists (AIOCD), has threatened to stop promoting Cipla products if it partners with Medlife.
“If the company could sell directly to the customer through online channels, what would we do? With such moves, companies will become the retailer and our business will be completely wiped out,” Rajiv Singhal, general secretary of the AIOCD
Cipla is reportedly in talks to invest over Rs 150 crore in the Bengaluru-based Medlife.
